Literature DB >> 9215705

Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum.

L Caberlotto1, K Fuxe, G Sedvall, Y L Hurd.   

Abstract

Many neurobiological functions have been ascribed to the NPY Y1 receptor subtype, but autoradiographic analysis has failed to detect Y1 binding sites in most human brain areas, in contrast to the rat. We examined the regional distribution of Y1 mRNA-containing cells in the post-mortem human brain to clarify if there is a major species difference in terms of the existence of Y1 receptors in the human telencephalon, in particular the striatum and cortex. In situ hybridization experiments revealed widespread distribution of Y1 mRNA signals in all layers of most limbic and neocortical regions, predominantly in layer IV (most cortical regions) and layer VI. The striatum showed moderate Y1 receptor mRNA expression levels with intensely expressing cells localized to the nucleus accumbens. The highest Y1 receptor mRNA expression was apparent within the dentate gyrus, and the lowest in the subiculum, parahippocampal gyrus, cerebellum, and thalamus. In vitro autoradiography using [125I]Leu31Pro34-PYY and [125I]PYY with NPY (13-36) or Leu31Pro34-NPY, confirmed the presence of low Y1-like binding in the human brain despite abundant Y1 mRNA expression. However, using a rat model of the human autopsy process, it was apparent that the inability to reveal high Y1- versus Y2-like receptors in the human brain was related in part to marked reductions of Y1-like, but not Y2-like, receptors within a 4 h post-mortem delay. Altogether, the results indicate that the Y1 receptor gene is abundant in the human brain and this receptor may have important roles in cognitive, limbic and motor function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215705     DOI: 10.1111/j.1460-9568.1997.tb01476.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.

Authors:  K A Nichol; A Morey; M H Couzens; J Shine; H Herzog; A M Cunningham
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

4.  Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy.

Authors:  S Furtinger; S Pirker; T Czech; C Baumgartner; G Ransmayr; G Sperk
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 5.  In vitro imaging techniques in neurodegenerative diseases.

Authors:  Bengt Långström; Per E Andrén; Orjan Lindhe; Marie Svedberg; Håkan Hall
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

6.  Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development.

Authors:  Sen Mun Wai; Pawel M Kindler; Edward T K Lam; Aiqun Zhang; David T Yew
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

7.  Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Authors:  Haley L Yarosh; Jesus A Angulo
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

8.  Neuropeptide Y receptor gene expression in the primate amygdala predicts anxious temperament and brain metabolism.

Authors:  Patrick H Roseboom; Steven A Nanda; Andrew S Fox; Jonathan A Oler; Alexander J Shackman; Steven E Shelton; Richard J Davidson; Ned H Kalin
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

9.  Neuropeptide Y receptors: how to get subtype selectivity.

Authors:  Xavier Pedragosa-Badia; Jan Stichel; Annette G Beck-Sickinger
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-04       Impact factor: 5.555

10.  Neuropeptide Y receptors: a promising target for cancer imaging and therapy.

Authors:  Juan Li; Yuchen Tian; Aiguo Wu
Journal:  Regen Biomater       Date:  2015-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.